Reader participation
I received an email from reader Doug Blank (who gave me permission to share it here and to identify him by name) about a perplexing situation:
Janet,
I thought I'd solicit your advice. Recently, I found an instance of parts of my thesis appearing in a journal article, and of the paper being presented at a conference. In fact, further exploration revealed that it had won a best paper prize! Why don't I feel proud...
I've sent the following letter to the one and only email address that I found on the journal's website, almost three weeks ago, but haven't heard anything. I tried contacting the…
The younger Free-Ride offspring's soccer team has been playing in a regional tournament this weekend, and we're girding our loins and guarding our shins to go out and play a second day of tournament games. I'm happy that they're playing so well, but I have to say, watching games in late November is a different experience than spectating in mid-September. (Bone-chilling cold + bad sunburn = some kind of tangible sign of a parent's devotion. If only one's child took it seriously.)
Anyway, in the meantime, I wanted to test your knowledge in the identification of some turkeys.
Specifically,…
There is a story posted at ProPublica (and co-published with the Chicago Tribune) that examines a particular psychiatrist who was paid by a pharmaceutical company to travel around the U.S. to promote one of that company's antipsychotic drugs. Meanwhile, the psychiatrist was writing thousands of prescriptions for that same antipsychotic drug for his patients on Medicaid.
You might think that there would be at least the appearance of a conflict of interest here. However, the psychiatrist in question seems certain that there is not:
In an interview and in response to written questions, […
You may remember my post from last week involving a case where a postdoc sued her former boss for defamation when he retracted a couple of papers they coauthored together. After that post went up, a reader helpfully hooked me up with a PDF of District Judge Joseph M. Hood's ruling on the case (Chandok v. Klessig, 5:05-cv-01076). There is a lot of interesting stuff here, and I'm working on a longer examination of the judge's reasoning in the ruling. But, in the interim, I thought you might be interested in the statements made by the defendant in the case, Dr. Daniel F. Klessig, that the…
In my philosophy of science class yesterday, we talked about Semmelweis and his efforts to figure out how to cut the rates of childbed fever in Vienna General Hospital in the 1840s. Before we dug into the details, I mentioned that Semmelweis is a historical figure who easily makes the Top Ten list of Great Moments in Scientific Reasoning. (At the very least, Semmelweis is discussed in no fewer than three of the readings, by three separate authors, assigned for the course.)
But this raises the question: what else belongs on the Top Ten list of Great Moments in Scientific Reasoning?
Given…
Ed Yong and DrugMonkey have dusted off the invitation (seen here last summer) for readers to take a moment to introduce themselves in the comments.
It seems like a good idea to me, so I'm going to play along:
Who are you? (Scientist, philosopher, other? Student, parent, working stiff, blissful retiree? Given that personal identity is a matter of deep philosophical import, I'm going to let you decide the right way to deal with this question.)
Have we met in real life? Before or after you first read the blog? (Are you now regretful of our real-life meeting?)
What brings you to this blog?…
In my last post, I mentioned Richard Gallagher's piece in The Scientist, Fairness for Fraudsters, wherein Gallagher argues that online archived publications ought to be scrubbed of the names of scientists sanctioned by the ORI for misconduct so that they don't keep paying after they have served their sentence. There, I sketched my reasons for disagreeing with Gallagher.
But there's another piece of his article that I'd like to consider: the alternative strategies he suggests to discourage scientific fraud.
Gallagher writes:
There are much better methods of subverting fraud. There is little…
This just came up in a plenary session I'm attending, looking at how best to convey the nature of science in K-12 science education (roughly ages 5-18).
It's not really a question about the content of the instruction, which people here seem pretty comfortable saying should include stuff about scientific methodology and critical testing, analysis and interpretation of data, hypothesis and prediction, what kind of certainty science can achieve, and so forth. Rather, it's a question about how that content is organized and framed.
It was proposed by one of the people in the room that an explicit…
A day later than promised, let's kick off our discussion of "Research Rashomon: Lessons from the Cameroon Pre-exposure Prophylaxis Trial Site" (PDF). The case study concerns a clinical trial of whether tenofovir, an antiretroviral drug, could prevent HIV infection. Before it was halted in the face of concerns raised by activists and the media, the particular clinical trial discussed in this case was conducted in Cameroon. Indeed, one of the big questions the activists raised about the trial was whether it was ethical to site it in Cameroon.
From the case study:
Tenofovir was first…
I have a quick question for the hive-mind:
Where are good places with free wifi in Boston, Cambridge, and Wellesley?
I'm heading off to my 20th college reunion and I am hopeful that an area as student-centered as the Boston metropolitan area will be brimming with free wifi. But, seeing as how I lived long enough to have my hopes dashed before, I figured it was worth asking for specific recommendations.
Anything close to a T-stop or stocked with pastries is a plus.
Thanks for helping keep me connected!
Almost a month ago, I told you about a pair of new case studies released by The Global Campaign for Microbicides which examine why a pair of pre-exposure prophylaxis (PrEP) clinical trials looking at the effectiveness of antiretrovirals in preventing HIV infection were halted. In that post, I also proposed that we read and discuss these case studies as a sort of ethics book club.
Next Monday, June 15, we'll be kicking off our discussion of the first case study, "Research Rashomon: Lessons from the Cameroon Pre-exposure Prophylaxis Trial Site" (PDF).
The case study is on the long side (54…
The Free-Ride family enjoyed a late breakfast (although you better believe that if either of the Free-Ride offspring claims to be hungry in the next two hours, I'm calling it an early lunch) at a local diner.
While there, the elder Free-Ride offspring struggled to eat an omelette off an unstable plate. Any attempt at cutting, spearing, or spooning sent the plate a-spinning.
Luckily, having some experience with diners (as a former Jersey girl), I was able to solve the problem quickly. All it took was placing two sugar packets under the plate (spaced about 180 degrees apart).
Then, it…
Earlier this week, I found out about a pair of new case studies being released by The Global Campaign for Microbicides. These cases examine why a pair of pre-exposure prophylaxis (PrEP) clinical trials looking at the effectiveness of microbicides antiretrovirals in preventing HIV infection were halted. Here are some details:
Between August 2004 and February 2005 the HIV prevention world was rocked by the suspension and cancellation of PrEP effectiveness trials in Cambodia and Cameroon. To the considerable surprise of researchers, advocates, and donors, the trials became embroiled in…
The other night as I was falling asleep, a situation occurred to me that struck me as something of a conundrum. (Remarkably, I still remembered the situation when I woke up.) I've been working out my own take on this situation -- what's at stake in responding to it one way or another -- but I wanted to canvass the commentariat for responses before I put my own analysis out there.
Here's the situation:
You're a member of the tribe of science. (Let's leave your position within the tribe unspecified -- you could be a student or a trainee, you could be a mid-career scientist, you could be a…